{{Rsnum
|rsid=865686
|Chromosome=9
|position=108126198
|Orientation=plus
|GMAF=0.3191
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 18.6 | 41.6 | 39.8
| HCB | 1.5 | 14.6 | 83.9
| JPT | 0.9 | 16.8 | 82.3
| YRI | 28.6 | 46.9 | 24.5
| ASW | 19.3 | 42.1 | 38.6
| CHB | 1.5 | 14.6 | 83.9
| CHD | 0.9 | 9.2 | 89.9
| GIH | 1.0 | 18.8 | 80.2
| LWK | 29.1 | 53.6 | 17.3
| MEX | 10.3 | 34.5 | 55.2
| MKK | 22.4 | 39.1 | 38.5
| TSI | 14.7 | 44.1 | 41.2
| HapMapRevision=28
}}{{PMID Auto
|PMID=21263130
|Title=Novel Breast Cancer Susceptibility Locus at 9q31.2: Results of a Genome-Wide Association Study
}}

{{PMID Auto
|PMID=22348646
|Title=Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers
|OA=1
}}

{{PMID Auto
|PMID=22859399
|Title=9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium
|OA=1
}}

{{PMID Auto GWAS
  |PMID=23535729
  |Trait=Breast cancer
  |Title=Large-scale genotyping identifies 41 new loci associated with breast cancer risk.
  |RiskAllele=T
  |Pval=1E-34
  |OR=1.12
  |ORtxt=[1.1-1.14]
  |OA=1
}}

{{PMID Auto
|PMID=25002657
|Title=Breast cancer susceptibility variants and mammographic density phenotypes in Norwegian postmenopausal women
}}
{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}